Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development

There is a need for definite diagnosis of rheumatoid arthritis (RA) at its earliest stages of development in order to introduce early and effective treatment. Here we assessed whether serum interleukin-15 (IL-15) can serve as a new biomarker of RA development in patients with undifferentiated arthri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurowska, Weronika, Przygodzka, Malgorzata, Jakubaszek, Michal, Kwiatkowska, Brygida, Maslinski, Wlodzimierz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291073/
https://www.ncbi.nlm.nih.gov/pubmed/32455601
http://dx.doi.org/10.3390/jcm9051555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291073/
https://www.ncbi.nlm.nih.gov/pubmed/32455601
http://dx.doi.org/10.3390/jcm9051555

Ejemplares similares